Ever Source Wealth Advisors, LLC Aquestive Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 278 shares of AQST stock, worth $1,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
278
Previous 144
93.06%
Holding current value
$1,957
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
129Shares Held
48.5MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$69.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$38.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$30.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$21 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$15.4 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $376M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...